
Woolly Hair Nevus: Unraveling the Genetic Threads of a Rare Hair Disorder
Unlock the genetic mysteries of woolly hair nevus. Explore how genetic testing aids diagnosis and management of this rare hair disorder for better patient care.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Unlock the genetic mysteries of woolly hair nevus. Explore how genetic testing aids diagnosis and management of this rare hair disorder for better patient care.

Explore the role of genetic testing in diagnosing X-linked intellectual disability with isolated growth hormone deficiency. Learn about early intervention and personalized care.

Explore X-linked nonsyndromic hearing loss, its genetic basis, and how genetic testing aids early detection, family planning, and personalized treatment strategies.

Explore how genetic testing enhances diagnosis and management of 46,XY ovotesticular DSD, providing insights into genetic factors, personalized care, and family planning.

Uncover how genetic testing aids in diagnosing and managing ABeta amyloidosis, Arctic type, improving life quality through early diagnosis, personalized care, and risk assessment.

Explore the vital role of genetic testing in diagnosing ABeta amyloidosis, Iowa type, for early detection, risk assessment, and personalized management strategies.

Explore how genetic testing aids in diagnosing ABeta amyloidosis, Italian type, enabling early detection, personalized treatment, and informed family risk assessment.

Genetic testing in ABetaA21G amyloidosis aids diagnosis, personalizes treatment, and predicts disease risk, enhancing management of this rare cardiac condition.